Advanced Clinical Research Inc

1. Emergent BioSolutions Inc. $3,095,755 3,569 payments
2. Allergan Inc. $731,038 103 payments
3. Pfizer Inc. $596,629 158 payments
4. Takeda Pharmaceuticals U.S.A., Inc. $427,345 33 payments
5. Eli Lilly and Company $248,069 47 payments
6. Boehringer Ingelheim International GmbH $165,827 35 payments
7. Ironwood Pharmaceuticals, Inc $157,933 11 payments
8. Janssen Research & Development, LLC $107,984 33 payments
9. Regeneron Pharmaceuticals, Inc. $90,067 32 payments
10. Moderna TX, Inc. $59,161 4 payments

1. VELOCITY: An Anthrax Vaccine Clinical Study $2,890,987 3,565 payments
2. A Phase 3, Multicenter, Randomized, Open-Label Study to Evaluate the Longterm Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Patients With Episodic Migraine $396,931 44 payments
3. Immunogenicity and Safety of Tetravalent Dengue Vaccine TDV Administered With a Yellow Fever Vaccine in Adults $282,799 9 payments
4. Ebs.Ava.212 $200,541 2 payments
5. A Phase 3 Placebocontrolled Randomized Observerblinded Study to Evaluate the Efficacy Safety and Tolerability of A Clostridium Difficile Vaccine in Adults 50 Years of Age and Older $163,506 59 payments
6. Phase III Lot Consistency Trial $159,863 16 payments
7. C3718-302 $157,933 11 payments
8. AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis $113,948 7 payments
9. MRD/PoCP study in NFLD (12 wks) $110,116 2 payments
10. Assessment of Safety, Tolerability, and Efficacy of Ly3303560 in Early Symptomatic Alzheimer's Disease $109,790 2 payments

1. Other $386,277 24 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.